• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologi

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Mar 29;14(1):7475.
doi: 10.1038/s41598-024-57817-1. Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologies

Finola Ryan[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Joanna Cole-Hamilton[SUP] #[/SUP][SUP] 1 [/SUP], Niharika Dandamudi[SUP] #[/SUP][SUP] 1 [/SUP], Matthias E Futschik[SUP] 1 4 [/SUP], Alexander Needham[SUP] 1 [/SUP], Rida Saquib[SUP] 1 [/SUP], Raghavendran Kulasegaran-Shylini[SUP] 1 [/SUP], Edward Blandford[SUP] 1 [/SUP], Michael Kidd[SUP] 5 [/SUP], Éamonn O'Moore[SUP] 6 [/SUP], Ian Hall[SUP] 7 8 [/SUP], Malur Sudhanva[SUP] 1 2 [/SUP], Paul Klapper[SUP] 1 9 [/SUP], Andrew Dodgson[SUP] 1 [/SUP], Adam Moore[SUP] 10 [/SUP], Madeleine Duke[SUP] 10 [/SUP], Sarah Tunkel[SUP] 1 [/SUP], Chris Kenny[SUP] 1 [/SUP], Tom Fowler[SUP] 11 12 [/SUP]



Affiliations
Abstract

To detect SARS-CoV-2 amongst asymptomatic care home staff in England, a dual-technology weekly testing regime was introduced on 23 December 2020. A lateral flow device (LFD) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) test were taken on the same day (day 0) and a midweek LFD test was taken three to four days later. We evaluated the effectiveness of using dual-technology to detect SARS-CoV-2 between December 2020 to April 2021. Viral concentrations derived from qRT-PCR were used to determine the probable stage of infection and likely level of infectiousness. Day 0 PCR detected 1,493 cases of COVID-19, of which 53% were in the early stages of infection with little to no risk of transmission. Day 0 LFD detected 83% of cases that were highly likely to be infectious. On average, LFD results were received 46.3 h earlier than PCR, enabling removal of likely infectious staff from the workplace quicker than by weekly PCR alone. Demonstrating the rapidity of LFDs to detect highly infectious cases could be combined with the ability of PCR to detect cases in the very early stages of infection. In practice, asymptomatic care home staff were removed from the workplace earlier, breaking potential chains of transmission.


 
Back
Top Bottom